Citigroup Initiates Coverage On Elanco Animal Health with Buy Rating, Announces Price Target of $30

Benzinga Newsdesk www.benzinga.com Neutral 71.5%

Neg 0% Neu 71.5% Pos 0%

Citigroup analyst Daniel Grosslight initiates coverage on Elanco Animal Health (NYSE:ELAN) with a Buy rating and announces Price Target of $30.